Back to Newsroom

Sucampo and Takeda Launch Direct-to-Consumer Advertising Campaign for AMITIZA(R) (lubiprostone) for Chronic Idiopathic Constipation

BETHESDA, Md., Sept. 29, 2014 (GLOBE NEWSWIRE) — Sucampo Pharmaceuticals, Inc.(Sucampo) (Nasdaq:SCMP) and its development and commercialization partner, Takeda Pharmaceuticals (Takeda), today announced the launch of a pilot direct-to-consumer advertising campaign in select U.S. markets for AMITIZA® (lubiprostone) for adults with chronic idiopathic constipation (CIC). The campaign will consist of a 60-second television spot that will air in programming including Good Morning America, Headline News Network, and the Oprah Winfrey Network, and a print advertisement that will run in outlets including USA Weekend,Good Housekeeping, and Woman’s Day.

Click here to read more